HEADER STRUCTURAL PROTEIN 16-MAY-05 1X5N TITLE SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HARMONIN PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HARMONIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PDZ DOMAIN; COMPND 5 SYNONYM: USHER SYNDROME 1C PROTEIN, AUTOIMMUNE ENTEROPATHY-RELATED COMPND 6 ANTIGEN AIE-75, PDZ-73 PROTEIN, ANTIGEN NY-CO-38/NY-CO-37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: USH1C; AIE75; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P040510-04; SOURCE 8 OTHER_DETAILS: CELL FREE PROTEIN SYNTHESIS KEYWDS PDZ DOMAIN, HARMONIN, USHER SYNDROME 1C PROTEIN, AUTOIMMUNE KEYWDS 2 ENTEROPATHY-RELATED ANTIGEN AIE-75, ANTIGEN NY-CO-38/NY-CO-37, PDZ- KEYWDS 3 73 PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN KEYWDS 4 STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL KEYWDS 5 GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR X.R.QIN,F.HAYASHI,S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 3 02-MAR-22 1X5N 1 REMARK SEQADV REVDAT 2 24-FEB-09 1X5N 1 VERSN REVDAT 1 16-NOV-05 1X5N 0 JRNL AUTH X.R.QIN,F.HAYASHI,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HARMONIN JRNL TITL 2 PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA 1.0.7 REMARK 3 AUTHORS : VARIAN (VNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1X5N COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000024409. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.13MM 13C, 15N-LABELED PROTEIN; REMARK 210 20MM D-TRIS-HCL; 100MM NACL; 1MM REMARK 210 D-DTT; 0.02% NAN3 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20020425, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9296, CYANA 1.0.7 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE A 43 H ILE A 65 1.52 REMARK 500 H ASN A 69 O THR A 92 1.53 REMARK 500 H VAL A 19 O ILE A 93 1.54 REMARK 500 H GLU A 60 OD2 ASP A 63 1.56 REMARK 500 O SER A 32 H SER A 46 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 108.59 -164.00 REMARK 500 1 SER A 3 117.30 -170.53 REMARK 500 1 ASN A 14 -57.64 -142.93 REMARK 500 1 GLU A 16 90.03 45.29 REMARK 500 1 ARG A 27 111.37 -178.83 REMARK 500 1 ASP A 63 98.31 -55.53 REMARK 500 1 ASN A 75 24.35 -154.62 REMARK 500 1 LEU A 76 -167.99 -78.45 REMARK 500 1 ALA A 97 94.02 44.33 REMARK 500 1 PHE A 104 -50.34 -124.55 REMARK 500 1 THR A 106 96.61 -43.47 REMARK 500 1 ASP A 107 141.21 73.37 REMARK 500 2 SER A 5 107.07 64.33 REMARK 500 2 ASN A 11 111.68 -177.06 REMARK 500 2 GLU A 13 87.94 60.76 REMARK 500 2 ASN A 14 -60.26 170.81 REMARK 500 2 GLU A 16 90.50 45.83 REMARK 500 2 SER A 26 88.72 46.66 REMARK 500 2 PRO A 37 -170.00 -74.98 REMARK 500 2 ASP A 63 97.39 -56.44 REMARK 500 2 ASN A 75 50.90 -142.22 REMARK 500 2 ALA A 97 93.79 45.21 REMARK 500 2 PHE A 104 59.28 -119.43 REMARK 500 3 SER A 5 80.07 48.71 REMARK 500 3 ASN A 11 138.16 -173.20 REMARK 500 3 ARG A 12 146.66 -176.05 REMARK 500 3 GLU A 16 90.91 48.50 REMARK 500 3 LEU A 29 109.78 62.20 REMARK 500 3 SER A 52 -159.28 -65.89 REMARK 500 3 ASP A 63 96.94 -43.99 REMARK 500 3 ALA A 97 94.84 46.76 REMARK 500 3 PHE A 104 52.23 -106.66 REMARK 500 3 ASP A 107 154.52 167.28 REMARK 500 3 SER A 112 -63.65 -92.46 REMARK 500 4 SER A 3 149.33 -179.92 REMARK 500 4 SER A 5 112.48 -178.71 REMARK 500 4 ASN A 11 151.82 177.21 REMARK 500 4 ASN A 14 -55.92 -179.66 REMARK 500 4 GLU A 16 89.66 43.21 REMARK 500 4 SER A 52 -164.39 -58.26 REMARK 500 4 ASP A 63 97.36 -60.25 REMARK 500 4 ASN A 69 18.29 57.15 REMARK 500 4 PHE A 73 41.21 -86.14 REMARK 500 4 SER A 74 -72.15 -82.84 REMARK 500 4 ASN A 75 47.11 -103.95 REMARK 500 4 ALA A 97 94.26 44.97 REMARK 500 4 ALA A 99 -75.46 -59.99 REMARK 500 5 SER A 2 108.12 -168.11 REMARK 500 5 ASN A 11 -55.37 -152.91 REMARK 500 5 ASN A 14 -59.49 173.60 REMARK 500 REMARK 500 THIS ENTRY HAS 282 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001003274 RELATED DB: TARGETDB DBREF 1X5N A 8 108 UNP Q9Y6N9 USH1C_HUMAN 201 301 SEQADV 1X5N GLY A 1 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 2 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 3 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N GLY A 4 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 5 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 6 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N GLY A 7 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 109 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N GLY A 110 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N PRO A 111 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 112 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N SER A 113 UNP Q9Y6N9 CLONING ARTIFACT SEQADV 1X5N GLY A 114 UNP Q9Y6N9 CLONING ARTIFACT SEQRES 1 A 114 GLY SER SER GLY SER SER GLY SER PRO GLY ASN ARG GLU SEQRES 2 A 114 ASN LYS GLU LYS LYS VAL PHE ILE SER LEU VAL GLY SER SEQRES 3 A 114 ARG GLY LEU GLY CYS SER ILE SER SER GLY PRO ILE GLN SEQRES 4 A 114 LYS PRO GLY ILE PHE ILE SER HIS VAL LYS PRO GLY SER SEQRES 5 A 114 LEU SER ALA GLU VAL GLY LEU GLU ILE GLY ASP GLN ILE SEQRES 6 A 114 VAL GLU VAL ASN GLY VAL ASP PHE SER ASN LEU ASP HIS SEQRES 7 A 114 LYS GLU ALA VAL ASN VAL LEU LYS SER SER ARG SER LEU SEQRES 8 A 114 THR ILE SER ILE VAL ALA ALA ALA GLY ARG GLU LEU PHE SEQRES 9 A 114 MET THR ASP ARG SER GLY PRO SER SER GLY HELIX 1 1 LYS A 79 SER A 88 1 10 HELIX 2 2 ARG A 101 THR A 106 1 6 SHEET 1 A 5 LYS A 17 ILE A 21 0 SHEET 2 A 5 LEU A 91 ILE A 95 -1 O ILE A 93 N VAL A 19 SHEET 3 A 5 GLN A 64 VAL A 68 -1 N GLU A 67 O SER A 94 SHEET 4 A 5 ILE A 43 VAL A 48 -1 N ILE A 43 O ILE A 65 SHEET 5 A 5 CYS A 31 SER A 35 -1 N SER A 32 O SER A 46 SHEET 1 B 4 LYS A 17 ILE A 21 0 SHEET 2 B 4 LEU A 91 ILE A 95 -1 O ILE A 93 N VAL A 19 SHEET 3 B 4 GLN A 64 VAL A 68 -1 N GLU A 67 O SER A 94 SHEET 4 B 4 VAL A 71 ASP A 72 -1 O VAL A 71 N VAL A 68 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1